Skip to main content

Colorectal Cancer Clinical Trials

Review the colorectal cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 201-225 of 444

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients with Peritoneal Metastases from Colorectal Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Yttrium Y-90 Radioembolization before Surgery for Tumor Control and Future Liver Remnant Hypertrophy Patients with Colorectal Liver Metastases
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for the Treatment of Patients with KRAS-Mutant Metastatic Colorectal Cancer
Status: Active
Location: USC / Norris Comprehensive Cancer Center, Los Angeles, California
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pooled Mutant KRAS-Targeted Long Peptide Vaccine with Balstilimab and Botensilimab for the Treatment of Patients with Stage IV Non-MSI-H/dMMR Colorectal Cancer and Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Trifluridine/Tipiracil in Combination with Talazoparib for the Treatment of Patients with Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Neoadjuvant Chemotherapy Combined with Magnetic Resonance Image Guided Pelvic Adaptive Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, SMART TNT Study
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Chemotherapy with Radiation for the Treatment of Rectal Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
CBP-1019 with FOLFOX with or without Bevacizumab, Pembrolizumab, or Enzalutamide for the Treatment of Metastatic Solid Tumors of Epithelial Origin
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of DM001 in Patients With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients with Advanced Solid Tumor Cancers Being Treated with Standard of Care Checkpoint Inhibitors
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Status: Active
Location: 2 locations
Papaverine Hydrochloride and Stereotactic Body Radiation Therapy in Treating Patients with Non-small Cell Lung Cancer or Lung Metastases
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Status: Active
Location: Hackensack University Medical Center, Hackensack, New Jersey
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Universal Donor Natural Killer Cells in Combination with Aldesleukin and Vactosertib for the Treatment of Patients with Locally Advanced or Metastatic Colorectal, Gastric and Esophageal Cancers and Relapsed or Refractory Hematologic Cancers
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Adaptive, Individualized Dose Escalation of the FOX Regimen for the Treatment of Metastatic or Locally Advanced/Inoperable Gastrointestinal Cancer
Status: Active
Location: Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Active Surveillance or Surgery in Treating Participants with Rectal Cancer, OPTION Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
CIMAvax-EGF in Combination with Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Circulating Tumor DNA for Risk Determination and Treatment Selection in Patients with Carcinomatosis from Colorectal or Appendiceal Adenocarcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama